QuidelOrtho to Report Second Quarter 2025 Financial Results

SAN DIEGO, July 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will report its financial results for its second quarter 2025 ended June 29, 2025, after the market close on Tuesday, August 5, 2025.Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2: ...